Interferons
Showing 26 - 50 of 1,152
COVID-19 Infection and Its Clinical Prognosis in Chronic
Recruiting
- Chronic Hepatitis B
- COVID-19 Infection
- Interferon
- nucleoside analogues
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023
Ingaron in Pulmonary Tuberculosis
Recruiting
- Respiratory Tuberculosis
-
Astrakhan, Astrakhan Oblast, Russian Federation
- +12 more
Nov 7, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2022
Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)
Not yet recruiting
- Membranous Nephropathy
- Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
-
Nice, FranceCHU de NICE
Jul 4, 2023
Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)
Recruiting
- Cervical Dysplasia
- HPV Infection
- gel Interferon arm
- gel Interferon and interferon suppository arm
-
Ulaanbaatar, MongoliaNational Cancer Center
Nov 14, 2023
COPD Exacerbation Acute, Ascaris Lumbricoides Infection, Chronic Pulmonary Aspergillosis Trial (Interleukin-1B, Interleukin-4,
Not yet recruiting
- COPD Exacerbation Acute
- +2 more
- Interleukin-1B
- +4 more
- (no location specified)
Mar 23, 2023
COVID-19, Children Trial in Shanghai (Inhaled Interferon a2b, Standard of Care)
Recruiting
- COVID-19
- Children
- Inhaled Interferon α2b
- Standard of Care
-
Shanghai, ChinaChildren Hospital of Fudan University
May 18, 2022
Eosinophilic Asthma Trial in Taipei (AD17002, Placebo)
Not yet recruiting
- Eosinophilic Asthma
- AD17002
- Placebo
-
Taipei, TaiwanTaipei Medical University Hospital
Aug 16, 2023
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
Systemic Lupus Erythematosus Trial in Bordeaux (blood sample)
Not yet recruiting
- Systemic Lupus Erythematosus
- blood sample
-
Bordeaux, FranceCHU de Bordeaux - Médecine Interne et Immunologie Clinique
Jan 13, 2023
Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma Trial run by the NCI (Interferon, Rituxan and
Recruiting
- Lymphomatoid Granulomatosis
- +3 more
- Interferon
- Rituxan and EPOCH
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)
Completed
- Multiple Sclerosis
- Interferon beta 1a, oral doxycycline
-
Shreveport, LouisianaLSU Health Sciences Center Shreveport
Oct 11, 2022
Covid-19; SARS-Cov2 Trial (Blood sampling, Nasal Brushing)
Not yet recruiting
- Covid-19; SARS-Cov2
- Blood sampling
- Nasal Brushing
- (no location specified)
Oct 24, 2022
Immune Disease Trial in Lille (Monoclonal anti-cd303 antibody)
Completed
- Immune Disease
- Monoclonal anti-cd303 antibody
-
Lille, FranceHôpital Claude Huriez, CHU
Aug 26, 2020
Multiple Sclerosis, Healthy Trial in Philadelphia (thoracic duct cannulation)
Not yet recruiting
- Multiple Sclerosis
- Healthy
- thoracic duct cannulation
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 6, 2021
Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded
Not yet recruiting
- Refractory Leukemia
- +4 more
- STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
- Dendritic Cell Vaccine
-
Miami, FloridaUniversity of Miami
Jan 23, 2023
Viral Upper Respiratory Tract Infection Trial (recombinant human interferon ? spray)
Not yet recruiting
- Viral Upper Respiratory Tract Infection
- recombinant human interferon ω spray
- (no location specified)
May 7, 2023
MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- IFN-γ (interferon gamma-1b) injection
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jan 5, 2023
Early Antiviral Responses to Rhinovirus Infection in Asthma
Not yet recruiting
- Asthma
- Rhinovirus infection
- (no location specified)
Mar 29, 2022
Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon
Not yet recruiting
- Breast Cancer
- +4 more
- SV-BR-1-GM
- +4 more
-
Port Jefferson Station, New YorkNew York Cancers & Blood Specialists
Oct 2, 2023
Systemic Lupus Erythematosus, Cardiovascular Disease, Premature Atherosclerosis Trial run by the National Institute of Arthritis
Not yet recruiting
- Systemic Lupus Erythematosus
- +2 more
- anifrolumab
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)
Not yet recruiting
- Essential Thrombocythemia
- Bomedemstat
- +4 more
- (no location specified)
Oct 6, 2023
HIV Trial in United States (Peginterferon alfa-2b)
Completed
- HIV Infections
- Peginterferon alfa-2b
-
Long Beach, California
- +14 more
Oct 28, 2021
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
Not yet recruiting
- SLE (Systemic Lupus)
- (no location specified)
Oct 1, 2023